ACSL6 Antikörper (AA 240-270)
Kurzübersicht für ACSL6 Antikörper (AA 240-270) (ABIN7479762)
Target
Alle ACSL6 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 240-270
-
Verwendungszweck
- ACSL6 Antibody
-
Aufreinigung
- Purified
-
Immunogen
- A portion of amino acids 240-270 from the human protein was used as the immunogen for this ACSL6 antibody.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Titration of the ACSL6 antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the ACSL6 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- ACSL6 (Acyl-CoA Synthetase Long-Chain Family Member 6 (ACSL6))
-
Andere Bezeichnung
- ACSL6
-
Hintergrund
- FACL6 is involved in activation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. It plays an important role in fatty acid metabolism in brain and the acyl-CoAs produced may be utilized exclusively for the synthesis of the brain lipid. FACL6 is expressed predominantly in erythrocyte precursors, in particular in reticulocytes, fetal blood cells derieved from fetal liver, haemopoietic stem cells from cord blood, bone marrow, and brain. Expression is low at earlier stages of erythroid development but is very high in reticulocytes. This protein is involved in myelodysplastic syndrome (MDS) with basophilia, acute myelogenous leukemia (AML) with eosinophilia, and acute eosinophilic leukemia (AEL). It is characterized by a chromosomal translocation t(5,12)(q31,p13) that involves ETV6 and ACSL6.
-
UniProt
- Q9UKU0
Target
-